IL6R and pancreatic neoplasm: CD59 has been reported to be highly expressed in patients with pancreatic cancer (Schmitt et al., 1999), and Pancreatic cancer-educated macrophages could up-regulate CD59 to protect cancer cells from CDC through the IL-6R/STAT3 signaling pathway (Ronghua Zhang et al., 2019).